Compositions and methods for enhancing contrast in imaging
Example compositions of liposomes with hydrophilic polymers on their surface, and containing relatively high concentrations of contrast-enhancing agents for computed tomography are provided. Example pharmaceutical compositions of such liposomes, when administered to a subject, provide for increased contrast of extended duration, as measured by computed tomography, in the bloodstream and other tissues of the subject. Also provided are example methods for making the liposomes containing high concentrations of contrast-enhancing agents, and example methods for using the compositions.
1. A method for imaging a subject, comprising introducing a composition into the bloodstream of the subject, wherein the composition comprises liposomes, the liposomes comprising:
at least one first lipid or phospholipid;
at least one second lipid or phospholipid which is derivatized with one or more polymers; and
at least one sterically bulky excipient capable of stabilizing the liposomes;
wherein the average diameter of the liposomes is less than about 150 nanometers, and wherein the liposomes encapsulate at least one iodinated nonradioactive contrast enhancing agent.
2. A method for imaging a subject, comprising:
introducing into the bloodstream of a subject a composition comprising liposomes comprising a phospholipid, a phospholipid which is derivatized with a polymer, and cholesterol, and encapsulating one or more iodinated nonradioactive contrast enhancing agents, and wherein the liposomes have an average diameter of less than 150 nm; and
generating images of a region of interest in the subject, wherein the iodinated nonradioactive contrast enhancing agents cause a contrast enhancement in the region of interest of at least 50 Hounsfield units for a duration of longer than five minutes.
3. The method of claim 2 , wherein the generating images comprises acquiring one or more images by computed tomography.
4. The method of claim 3 , wherein the images are used for one or more of detection, quantification, characterization, classification, and monitoring of ischemia and/or myocardial microcirculatory insufficiencies.